malabarjackpot| Jincheng Pharmaceutical: The company has successfully implemented biosynthetic products such as glutathione, adenosylmethionine, astaxanthin, and PQQ, as well as enzymatic products such as 4-AA and nicotine

Tonghuashun (300033) Financial Research Center, May 07malabarjackpot, an investor asked Jincheng Pharmaceutical (300233)(300233) that synthetic biology currently generates revenue to your companymalabarjackpotWhat products are there and what products will be put into production in the future?

The company replied, Hello, investors! The company has been deeply engaged in the field of synthetic biology for many years, has built an internationally leading synthetic biology industrialization platform, and has successfully implemented biosynthetic products such as glutathione, adenosylmethionine, astaxanthin, and PQQ, as well as 4-AA, nicotine, etc. Enzyme catalyzed products. The company has established close industry-university-research cooperation and platform co-construction with authoritative teams in the field, forming a complete synthetic biology industry chain from upstream research and development, pilot scale expansion to industrialization. Currently, there are many products under research, and the company will actively promote the progress of product research and development to achieve industrialization as soon as possible. Thank you for your attention to the company!